The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

C-reactive protein blood test

Revealing Inflammation

You may have read about the “new” C-reactive protein (CRP) blood test that can help predict heart disease risk. CRP’s use as a marker for cardiovascular problems may be relatively new, but scientists have known the value of CRP for indicating the presence of inflammation for more than 60 years.

Now a new study shows that a CRP test may also be a good indicator of risk for a very common type of cancer – and it’s a cancer that’s more successfully treated when caught early.
Getting a clue

As I’ve told you in previous e-Alerts, C-reactive protein is produced by the liver in response to inflammation. Over the years, researchers have found high levels of CRP to be associated with various chronic health problems, including stroke and diabetes. Recently, a team headed by researchers at the Johns Hopkins Bloomberg School of Public Health, reported on a population-based study designed to see if there’s a link between elevated CRP levels and colorectal cancer.

Researchers used data collected from a study called CLUE II (named for a campaign called “Give Us a Clue to Cancer and Heart Disease”), conducted in Maryland. The records of nearly 23,000 adults included blood tests and health questionnaires. Additional data was gathered on the subjects for more than 10 years.

The Hopkins team identified 172 cases of colorectal cancer, and compared the data for these cases against 342 control subjects who were cancer-free, but matched the cancer subjects by age, sex and race.

The results showed that CRP levels were about the same among those with rectal cancer and subjects in the control group. But researchers determined that CRP levels were significantly higher among those with colon cancer. Overall, the highest levels of CRP indicated double the risk of developing colorectal cancer and two and a half times the risk of colon cancer, compared with subjects with the lowest CRP levels.

Writing in a recent issue of the Journal of the American Medical Association, Thomas P. Erlinger, M.D. (lead author of the study), noted that although elevated CRP was clearly linked to colorectal and colon cancer risk in this study, further research is needed in order to define exactly how CRP measurements might be used in screening and prevention of the diseases.

Inside peek

Because CRP levels can be measured with a simple blood test, this inflammation marker is quickly becoming one of the most critical tools in assessing risk of chronic health problems. So the next time you have a physical exam, ask your doctor to check your CRP. If it’s elevated, and if you also have a family history of colorectal cancer, your doctor will probably suggest that you have a colonoscopy exam – especially if you’re over the age of 50.

The importance of managing the development of colon polyps can’t be overstated. An estimated 10% of all cancer deaths in the U.S. are the result of colorectal cancer, and the key to prevention of the disease is colonoscopy, which not only looks for cancer polyps, but also removes them. When precancerous polyps are removed, the risk of developing colorectal cancer is sharply reduced.


Beyond CRP and colonoscopy

In three previous e-Alerts I examined studies that reveal simple steps you can take to help prevent colorectal and colon cancer.

In the e-Alert “Mass Communication” (1/13/04), I told you about a study of more than 3,000 subjects, aged 50 to 75 years, who were screened for colon cancer. Using dietary questionnaires, researchers found a clear association between vitamin D intake of more than 645 IU per day and a reduced risk of colon cancer. Those who had the greatest protection also used multivitamins, exercised regularly, and had diets with high fiber content. Moderate sun exposure, wild salmon and cod liver oil supplements are excellent sources of vitamin D.

Multivitamin use was also examined in a 2003 study conducted by the American Cancer Society. More than 145,000 subjects participated in the study that ran between 1992 and 1997. Researchers found that among subjects who began taking multivitamins just prior to the 1992 enrollment, there was no association with a reduced risk of colorectal cancer. But the participants who had reported regular multivitamin use (4 or more times per week) in the early 80s, fared much better: their group had a 30 percent reduced risk of the cancer.

And in the e-Alert “Invoking the 25th” (7/11/02), I told you about a University of Minnesota study of more than 1,700 subjects that showed how a diet containing ample amounts of fruits and vegetables may be a significant factor in preventing precancerous polyps from developing into cancer. Results also showed that women who drank the most fruit juice reduced their risk of developing polyps by half. The researchers speculate that the high folate intake from orange juice probably contributed to this resistance to polyp development. Why this “juice effect” didn’t hold true for men couldn’t be answered by the study.

Exactly how CRP levels may be affected by dietary factors, multivitamin use and vitamin D remains to be seen. In the meanwhile, it appears that the growing importance of CRP now includes a novel way to help predict colorectal cancer.

To Your Good Health,

Jenny Thompson
Health Sciences Institute

Sources:
“C-Reactive Protein and the Risk of Incident Colorectal Cancer” Journal of the American Medical Association, Vol. 291, No. 5, jama.ama-assn.org
“Inflammation Marker Predicts Colon Cancer” Johns Hopkins Medical Institutions Press Release, 2/5/04, sciencedaily.com
“Risk Factors for Advanced Colonic Neoplasia and Hyperplastic Polyps in Asymtomatic Individuals” Journal of the American Medical Association, vol. 290, no. 22, 12/10/03, ncbi.nlm.nih.gov
“Vitamin D Reduces Colon Cancer” Dr. Joseph Mercola, 1/3/04, mercola.com
“Fruits, Vegetables, and Adenomatous Polyps – The Minnesota Cancer Prevention Research Unit Case-Control Study” American Journal of Epidemiology, Vol. 155, 2002, aje.oupjournals.org

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.